FDA 483 - Philips Medical Systems Nederland B.V. - January 17, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Philips Medical Systems Nederland B.V. was inspected regarding its medical device manufacturing operations. The inspection revealed significant deficiencies in reporting corrections and removals, conducting adequate risk analyses for its IntelliSpace Cardiovascular software, and establishing proper complaint handling procedures, including failures to report potential risks to the FDA and adequately escalate software defects. These issues are serious, as they involve allegations of patient harm and death related to software malfunctions.
ID · d6d01afe-edd2-4a91-97cd-69ff13159e2a